|
GB0425085D0
|
|
Virus detecting method primers therefor and screening kit
|
|
GB0423138D0
|
|
Virus detection method,primers therefor and screening kit
|
|
GB0410892D0
|
|
Virus detection method, primers therefor and screening kit
|
|
GB0410763D0
|
|
Cellular targeting agents
|
|
GB0410761D0
|
|
Variants of the ADAM 12 gene
|
|
GB0410177D0
|
|
Engineered tubular tissue structures
|
|
GB0408409D0
|
|
Virus detection method, primers therefor and screening kit
|
|
GB0406786D0
|
|
Cellular targeting agents
|
|
GB0406180D0
|
|
Variants of the Adam 12 Gene
|
|
GB0405381D0
|
|
A method and means for treating heart failure
|
|
GB0404660D0
|
|
Screening method
|
|
AU2003300175A1
|
|
Hcmv derived immunomodulatory polypeptide
|
|
GB0322807D0
|
|
SNPs and haplotype association with disease
|
|
GB0321805D0
|
|
Human tumour growth patterns
|
|
GB0308240D0
|
|
Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene
|
|
GB0308242D0
|
|
Growth hormone variations in humans and their uses
|
|
GB0308241D0
|
|
Screening methods and sequences relating thereto
|
|
GB0306417D0
|
|
Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene
|
|
GB0305625D0
|
|
Variants of the adam 12 gene
|
|
GB0303367D0
|
|
Immunomodulatory polypeptide
|
